Total Funding
49
17
Total FundingVenture - Series Unknown raised
Growth Score
-4 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
84522
Trinomab is a Healthcare company.
Huaxin Liao: Co-founder, Chairman & CTO- Zheng Weihong: Chief Executive Officer & President & Co-Founder
About the Company
Trinomab Biotech is a clinical-stage biopharmaceutical company specializing in the discovery and development of novel fully native human monoclonal antibody (mAb) drugs. The company's core technology is known as HitmAb, a proprietary technology platform with differentiated advantages and high efficiency for the discovery of fully native human
mAbs against infectious diseases, autoimmune disorders, malignant tumors, and other human diseases.
